TONIX PHARMACEUTICALS HOLDING CORP. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $571.33 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2012-11-14
- TONIX PHARMACEUTICALS HOLDING CORP. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2012-09-30 was $342.80K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2012-09-30 | $342.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $571.33K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $228.53K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |